Form 4 for PGNY Progyny, Inc.
Accepted 2022-01-03 00:00:00 ET · period of report 2021-12-29 · accession 0001179110-22-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-03 | 2021-12-29 | PGNY | Schlanger David J | Executive COB, Dir | M - OptEx | $0.91 | +73.1K | 73.1K | New | +$66.5K |
| D | 2022-01-03 | 2022-01-01 | PGNY | Schlanger David J | Executive COB, Dir | A - Grant | $0.00 | +84.0K | 84.0K | New | $0 |
| D | 2022-01-03 | 2021-12-29 | PGNY | Schlanger David J | Executive COB, Dir | S - Sale+OE | $52.18 | -73.1K | 0 | -100% | -$3.81M |
| D | 2022-01-03 | 2022-01-01 | PGNY | Schlanger David J | Executive COB, Dir | A - Grant | $0.00 | +333.0K | 333.0K | New | $0 |
| D | 2022-01-03 | 2021-12-29 | PGNY | Schlanger David J | Executive COB, Dir | M - OptEx | $0.00 | -73.1K | 2.23M | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-29 | M | A | 73,095 | $0.91 | 73,095 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-01 | A | A | 84,000 | $0.00 | 84,000 | D | — | — | (F4) Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. |
| 3 | Common | Common Stock | 2021-12-29 | S | D | 73,095 | $52.18 | 0 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.11 to $52.39, inclusive. (F3) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2022-01-01 | A | A | 333,000 | $0.00 | 333,000 | D | $50.35 · — to 2031-12-31 | 333,000 Common Stock | (F6) One-fourth (1/4th) of the shares subject to the option will vest January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2021-12-29 | M | D | 73,095 | $0.00 | 2,234,384 | D | $0.91 · — to 2027-08-03 | 73,095 Common Stock | (F5) One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. |